Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer's Q1 Sales Rise 14 Percent, Though Profit Dips 38 Percent

NEW YORK (GenomeWeb News) — PerkinElmer today said first-quarter 2007 revenues increased 14 percent as R&D spending rose 22 percent and profit fell 38 percent.
Total receipts for the three months ended April 1 increased to $403 million from $355.5 million year over year, PerkinElmer said. 
Revenue for the company’s Life and Analytical Sciences business was up 14 percent to $299.5 million and Optoelectronics revenue was up 11 percent to $103.4 million year over year.
Health Sciences receipts accounted for 84 percent of total revenue for the quarter and was “driven primarily by strong growth in genetic screening, medical imaging, and service as a result of new products, key customer wins and market expansion,” PerkinElmer said.
R&D spending in the quarter increased to $27.8 million from $22.8 million year over year.
PerkinElmer said first-quarter profit fell to $14.7 million from $23.6 million in the year-ago period.
PerkinElmer said it expects second-quarter revenue to rise “by low double digits.”
CEO Gregory Summe said PerkinElmer expects “our momentum to continue through the year, as our new products and services continue to make a greater contribution to our overall revenue."
PerkinElmer had around $119.6 million in cash and cash equivalents and $4.6 million in marketable securities and investments as of April 1.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.